PAR •
Healthcare •
Diagnostics & Research •
Quote as of 06/12/2026
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangePAR
Market Capitalization8,769.89 mln
Float40.29 mln
Earnings Date09/04/2026
EPS
3.34
Solid
P / E
20.28
Premium valuation
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.88
Likely reliable
1-Year Forecast
96.51
Exceptional upside
Relative Strength
13
/ 100
Significantly lagging
Business Description
Founded in 1963 and headquartered near Lyon, France, bioMérieux is a global leader in medical diagnostics, helping healthcare professionals and food safety experts detect infectious diseases and harmful microorganisms quickly and accurately. The company develops and sells a wide range of testing systems, instruments, and software used in hospitals, laboratories, and industrial settings across more than 160 countries. As a subsidiary of Institut Mérieux, bioMérieux serves both clinical and industrial customers, offering solutions that support faster diagnosis, better treatment decisions, and safer food production.
